NeuroPace (NPCE) Assets Average (2021 - 2026)
NeuroPace's (NPCE) quarterly Assets Average came in at $102.2 million in Q1 2026, little changed year-on-year from $102.4 million in Q1 2025, and down 3.93% quarter-over-quarter from $106.4 million in Q4 2025.
NeuroPace (NPCE) Assets Average (2021 - 2026) Analysis & Trends
NeuroPace's Assets Average history runs 6 years deep, the most recent figure standing at $102.2 million for Q1 2026.
- On a quarterly basis, Assets Average changed 0.19% year-over-year to $102.2 million in Q1 2026; TTM through Mar 2026 was $102.2 million, a 0.19% change from a year earlier, with the FY2025 full-year figure at $100.1 million, down 1.03% from the prior year.
- Assets Average declined to $102.2 million in Q1 2026 per NPCE's latest filing, from $106.4 million in the prior quarter.
- Across five years, Assets Average topped out at $131.3 million in Q1 2022 and bottomed at $95.3 million in Q3 2024.
- The 5-year median for Assets Average is $104.3 million (2023), against an average of $107.5 million.
- Biggest YoY gain for Assets Average was 147.04% in 2022; the steepest drop was 17.07% in 2022.
- Year by year, Assets Average stood at $117.3 million in 2022, then slipped by 11.78% to $103.5 million in 2023, then dropped by 7.73% to $95.5 million in 2024, then rose by 11.45% to $106.4 million in 2025, then declined by 3.93% to $102.2 million in 2026.
- Per Business Quant, the three latest NPCE Assets Average figures stand at $102.2 million (Q1 2026), $106.4 million (Q4 2025), and $106.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 102.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.23 Mn |
| Dec 31, 2025 | 106.41 Mn |
| Sep 30, 2025 | 106.68 Mn |
| Jun 30, 2025 | 108.16 Mn |
| Mar 31, 2025 | 102.43 Mn |
| Dec 31, 2024 | 95.48 Mn |
| Sep 30, 2024 | 95.35 Mn |
| Jun 30, 2024 | 96.62 Mn |
| Mar 31, 2024 | 103.25 Mn |
| Dec 31, 2023 | 103.48 Mn |
| Sep 30, 2023 | 100.77 Mn |
| Jun 30, 2023 | 104.25 Mn |
| Mar 31, 2023 | 110.19 Mn |
| Dec 31, 2022 | 117.29 Mn |
| Sep 30, 2022 | 119.51 Mn |
| Jun 30, 2022 | 123.76 Mn |
| Mar 31, 2022 | 131.27 Mn |
| Dec 31, 2021 | 137.41 Mn |
| Sep 30, 2021 | 144.11 Mn |
| Jun 30, 2021 | 98.65 Mn |